Anna Sallfors Holmqvist, MD, PhD^1*, Yanjun Chen, MS^2*, Jessica Wu, MPH^2*, Lindsey Hageman, MPH^2*, Kevin D. Battles, BS^2*, Liton F. Francisco, BS^2*, Michelle Kung, MA^2*, Frederick Goldman, MD, MS³, Joseph Rosenthal, MD, MS⁴, Stephen J. Forman, MD⁵, Daniel J. Weisdorf, MD⁶, Mukta Arora, MD⁷, Saro H. Armenian, DO, MPH⁸ and Smita Bhatia, MD, MPH²

¹Department of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³Department of Pediatrics, UAB, Children's Hospital of Alabama, Birmingham, AL
⁴Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁵Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁶Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
⁷Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁸Department of Population Sciences, City of Hope, Duarte, CA

Michael Scordo, MD¹, Lihua E Budde, MD, PhD², Mehrdad Abedi, MD³, Carolyn Mulroney, MD⁴, Bita Fakhri, MD, MPH⁵, Attaphol Pawarode, MD PhD⁶, Bhagirathbhai Dholaria, MBBS⁷, Edward Kavalerchik, MD⁸, Sanjay K. Aggarwal, MD^9*, Muzaffar H. Qazilbash, MD¹⁰, Paul Finnegan, MD¹¹ and Sergio A. Giralt, MD^12,13

¹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
²T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³UC Davis Medical Center, Sacramento, CA
⁴UCSD Moores Cancer Center, La Jolla, CA
⁵Division of Hematology and Oncology, University of California, San Francisco, CA
⁶Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
⁷Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical center, Nashville, TN
⁸Clinical Development, Angiocrine Bioscience, San Francisco, CA
⁹Clinical Development, Angiocrine Bioscience, San Diego, CA
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Angiocrine Bioscience, San Diego, CA
¹²Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Memorial Sloan Kettering Cancer Center, New York, NY

Johannes Frasez Sørensen^1*, Anni Aggerholm^1*, Marcus H Hansen, MSc^1*, Gitte Birk Kerndrup, MD, DMSc^2*, Lene Hyldahl Ebbesen, MD, PhD^1*, Peter Hokland, MD, DMSc³, Anne Stidsholt Roug, MD, PhD^4* and Maja Ludvigsen, MSc, PhD^1,3*

¹Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
²Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
³Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
⁴Aalborg University Hospital, Aalborg, DNK

Peng Zhao^1,2,3,4*, Ye-Jun Wu^2,3,4,5*, Qing-Yuan Qu^2,3,4,5*, Shan Chong^2,3,4,5*, Xiao-Wan Sun^2,3,4,5*, Rui-Xin Deng^2,3,4,5*, Xiao Liu^1,2,4,6*, Xiao-Lu Zhu^2,3,4,5*, Wei Han^1,2,3,4*, Yuan-Yuan Zhang^2,3,4,5*, Feng-Rong Wang^2,3,4,5*, Xiao-Dong Mo^2,3,4,5*, Chen-Hua Yan^2,3,4,5*, Jing-Zhi Wang^2,3,4,5*, Yu Wang^2,3,4,5*, Huan Chen^2,3,4,5*, Yu-Hong Chen^2,3,4,5*, Xiang-Yu Zhao^2,3,4,5*, Ying-Jun Chang^2,3,4,5, Lan-Ping Xu^2,3,4,5*, Kaiyan Liu^1,2,4,6, Xiao-Jun Huang^2,3,4,5* and Xiao-Hui Zhang^2,3,4,5*

¹Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
²National Clinical Research Center for Hematologic Disease, Beijing, China
³Collaborative Innovation Center of Hematology, Peking University, Beijing, China
⁴Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
⁶Collaborative Innovation Centre of Hematology, Peking University, Beijing, China

Radhika Gangaraju, MD¹, Yanjun Chen, MS^1*, Lindsey Hageman, MPH^1*, Jessica Wu, MPH^1*, Liton F. Francisco, BS^1*, Michelle Kung, MA^1*, Daniel J. Weisdorf, MD², Stephen J. Forman, MD³, Mukta Arora, MD⁴, Saro H. Armenian, DO, MPH⁵ and Smita Bhatia, MD, MPH¹

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁴Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁵Department of Population Sciences, City of Hope, Duarte, CA

Prioty Islam, MD¹, Haesu Jin, RN, BSN, BMTCN^1*, Felicia Cao, MD, PhD^1*, Lauren M. Bohannon, BS^1*, Yi Ren, MS^2*, Nelson J. Chao, MD, MBA^1,3, Taewoong Choi, MD^1,3, Cristina Gasparetto, MD^1,3, Mitchell E. Horwitz, MD^1,3, Gwynn D. Long, MD^1,3*, Richard D. Lopez, MD^1,3*, David A Rizzieri, MD^1,3, Stefanie Sarantopoulos, MD, PhD^1,3 and Anthony D. Sung, MD^1,3

¹Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
²Biostatistics Shared Resources, Duke Cancer Institute, Durham, NC
³Duke Cancer Institute, Duke University Medical Center, Durham, NC